In total, 124 adult patients in remission after allogeneic hematopoietic SCT (HSCT) participated in a crosssectional study to assess health-related quality of life (HRQL). Assessment of HRQL was carried out using two questionnaires: the (EORTC QLQ-C30) and the Functional Assessment of Cancer Therapy (FACT) with specific modules for BMT (FACT-BMT). Transplanted patients differed from healthy controls in many HRQLrelated dimensions in the EORTC QLQ-C30: social functioning 73.4 versus 85.8, Po0.0001; role functioning 74.6 versus 83.3, Po0.004; physical functioning 83.9 versus 89.9, Po0.001; emotional functioning 72.2 versus 82.8, Po0.0001 but were not significant for global HRQL 71.2 versus 75.3, Po0.03. In total, 60% of the patients returned to work after HSCT; 31% part time and 29% full time. Age at HSCT and employment status were significantly associated with HRQL. Other factors such as disease and disease stage and especially the occurrence of late complications did not impact the perception of HRQL. This study suggests that the perception of HRQL after HSCT differs from the general population. Issues to increase work-related capabilities and improve social support need to be addressed.
Introduction
There has been a growing interest in quality-of-life evaluation following cancer treatment, including hematopoietic SCT (HSCT). [1] [2] [3] Information about health-related quality of life (HRQL) provides a broader understanding of the patient's status after treatment beyond simple diseasefree survival time. Hence, HRQL is now considered an index of the effectiveness of treatment and should become an integral component in the assessment of medical outcome. HRQL is a multidimensional phenomenon consisting of physical, psychological and social components following HSCT. Individual HRQL may be affected in any or all of these three areas. Accurate information regarding the HRQL is essential for programs devoted to inform potential transplant recipients and family members who are attempting to make decisions regarding HSCT. Awareness of long-term effects (including psychosocial distress) that may affect HRQL can also guide program revisions to decrease potential problematic side effects. 1, [3] [4] [5] [6] [7] The aim of this study was to assess HRQL using the Functional Assessment of Cancer Therapy scale with specific modules for BMT (FACT-BMT) and the European Organization for Research and Treatment of Cancer (EORTC QLQ-C30) questionnaires in patients of a single institution after allogeneic HSCT and free of disease at the time of evaluation. These two instruments focus possibly on different aspects of HRQL. 8, 9 These results were compared with those obtained from healthy controls. In addition, information on long-term effects, social issues, demographic and work-related variables was included.
Patients and methods

Patients
Eligible patients had undergone allogeneic HSCT between 1984 and 2004 at the University Hospital of Geneva, without evidence of persistent or recurrent disease at the time of answering the questionnaire (March 2005). Patients were French-, German-or English-speaking Swiss residents. The Institutional Ethics Committee approved the protocol and participants consented to this study. All patients were followed regularly in the outpatient facility. Patients completed the self-assessment questionnaires (EORTC QLQ-C30 (version 3) and the FACT-BMT) and mailed them back to the principle investigator. Patients had the opportunity to contact the investigators to address any question they might have and to receive additional help to answer the survey if necessary. Employment and marital status prior to transplant and at the time of the present survey were included in the questionnaire. Questionnaires were sent out in March 2005. Clinical data were obtained from medical charts or retrieved from the transplant program database.
Out of 316 recipients of allogeneic HSCT between 1984 and 2004, 134 patients, alive, without evidence of disease, and eligible for this study were contacted and 124 (94%) patients participated in the study. The median time from HSCT was 7.3 years (interval 1-21 years). The time interval from HSCT to assessment was o5 years for 48 patients and 45 years for 76 patients. Patient and treatment characteristics are given in Table 1 . Low-risk patients were defined as patients either in first CR of acute leukemia, or in the first chronic phase of CML at the time of transplant or with aplastic anemia. All other patients were considered high risk.
Treatment characteristics
Pre-transplant conditioning was by standard (n ¼ 105) or reduced (n ¼ 13) intensity. Standard conditioning was either based on TBI (n ¼ 90) or on chemotherapy alone (n ¼ 15). TBI for standard conditioning was delivered in six fractions, two fractions per day separated by at least 8 h. The lung dose was always limited to a maximum dose of 10 Gy by customized blocks. 10 The prescribed dose was 10, 12 or 13.5 Gy according to successive conditioning protocols and patient age. 11, 12 GVHD prophylaxis consisted of T-cell depletion by Campath 1H with or without T cell add-back in addition to CYA with methotrexate or with mycophenolate or no additional treatment. 13, 14 In total, 22 high-risk patients had a T-cell replete graft with standard GVHD prophylaxis with CYA and methotrexate. GVHD was graded according to standard criteria. 15 Late complications Late complications were defined as chronic GVHD of any grade, visual impairment, cataract, avascular osteonecrosis or other bone events, pain and/or weakness related to peripheral neuropathy or neurological impairment, clinical depression and secondary malignancies.
The median age at time of answering the questionnaire was 42 years (range: 19-67 years). Median Karnofsky performance score 16 at that time was 90 (range: 50-100). A total of 115 late complications occurring in 57 patients were recorded and are summarized in Table 1 . Chronic GVHD was observed in 27% of the patients (limited disease in 22 patients and extensive disease in 12 patients). Forty patients (32%) developed ocular side effects: cataract was diagnosed in 24 patients (19%), 16 patients presented with other ocular impairment, sicca syndrome (positive Schirmer's test) and corneal damage, and 1 patient was blind due to bilateral viral chorioretinitis. Eleven patients (9%) presented with some degree of neurological impairment. Seven patients had distal leg pain and hypoesthesia, including one patient with bilateral weakness in the popliteal sciatic nerve territory. One patient each had a transient ischemic attack and a toxic acute transverse spinal cord syndrome with paraplegia and hearing loss. Depressive disorders requiring psychological and pharmacological support were diagnosed in 15 patients (12%). Five patients presented with seven major bone complications, including bilateral femoral head osteonecrosis and pathological fractures. Ten patients (8%) developed a secondary malignancy: muco-epidermoid carcinoma of the parotid gland (2), localized prostate adenocarcinoma (2), poorly differentiated endocervical adenocarcinoma (1), lower limb osteosarcoma (1), breast cancer (1), follicular-derived papillary carcinoma of the thyroid (1) and malignant melanoma (2). Abbreviation: HSCT ¼ hematopoietic SCT.
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Questionnaires
The EORTC QLQ-C30, a cross-culturally validated questionnaire, 17 is a general quality-of-life tool made up of 30 questions that have been chosen to cover symptoms common to a wide range of cancers. The EORTC QLQ-C30 is a patient self-rating questionnaire that comprises six multi-item function scales measuring physical, role, social, emotional and cognitive functions, and overall quality of life (HRQL). Separate symptom scales are included to assess pain, fatigue and emesis, and five single items to measure gastrointestinal symptoms, dyspnea, appetite loss and sleep disturbances. A final item evaluates the perceived economic consequences of the disease. The reliability of the EORTC QLQ-C30 in HSCT recipients has been validated. Results were compared with reference values from a Norwegian population of comparable age and gender composition. 18 We used normal values for the ages 18-60 years, as these covered the age range of the patients studied.
The FACT follows a modular design, consisting of a general core questionnaire (FACT-G) and site-specific modules for patients who underwent HSCT. It has undergone extensive psychometric testing. 19 Patients can complete the FACT-G in roughly 10 min; FACT is designed for self-assessment and consists of 27 items to be rated on a five-point Likert scale. For the purpose of this study, the FACT-BMT scale (version 4) was chosen. FACT-BMT was designed to measure HRQL after HSCT and has been validated. 9 The FACT-BMT consists of the 27-item FACT-G and the 23-item BMT subscale. The latter assesses the effects of specific BMT-related issues. The FACT-BMT assesses the effects of cancer therapy on patients in four areas: physical, social/family, emotional and functional well-being. A higher score indicates better HRQL. Data from patients were compared to reference values obtained from a healthy Austrian population. 20 This reference population has an age and gender composition comparable to the patients studied. Furthermore, Austria resembles Switzerland in many ways. We have not found published reference values for healthy Swiss people.
Statistical analysis
All scores of the QLQ-C30 are linearly transformed so that all scales range from 0 to 100. For some analyses, the global HRQL score was dichotomized into good versus poor quality of life (80-100, versus 0-79). The higher scale score represents a higher level of functioning for the six (QLQ-C30) multi-item/single function scales and a higher level of symptomatology/problems for the symptom/single-item scales. The subscores of the FACT-G were calculated according to the directions provided in the manual; higher subscale scores mean higher HRQL. Descriptive statistics were performed on all the study variables. The one-sample t-test was used to assess whether the test population differed significantly from the mean of the respective reference population. The Mann-Whitney U-test was used to assess the relationship between the different HRQL scores and the clinical factors, and the simple regression test for the relationship between the different scores. Because of multiple testing, a difference with a P-value o0.01 was considered significant. All variables significantly affecting selected function scales of global HRQL on univariate analysis were tested in a multivariate logistic regression model. 21 Age at HSCT, age at HRQL, diagnosis, gender, source, Karnofsky score, employment status, T-cell depletion, donor recipient gender combination, marital and employment status, time interval between HSCT and HRQL, risk category and late complications were analyzed.
Results
Correlation coefficient between HRQL as measured by the EORTC QLQ-C30 and by FACT-G was 0.71 and the R 2 was 0.51 (P-value o0.0001). There was no evidence for a change in HRQL perception with time after transplantation (Figure 1 ), in particular there was no improvement in HRQL with increasing distance from HSCT.
HRQL measured by the EORTC QLQ-C30 and by FACT-G Patient's HRQL measured by EORTC QLQ-C30 scores differed significantly from general population. As shown in Table 2 , there were significant differences in the following dimensions: physical function, role function, social function, emotional functioning but no significant difference for global quality of life. Items differing in patients from the reference population were fatigue, dyspnea, sleep disturbances and financial impact. Table 2 also illustrates the four FACT-G subscales for the patient population compared with the control group (aged 18-54 years). Patients rated significantly worse on most of the dimensions of the FACT-G and on the specific subscales of FACT-BMT. Table 3 shows function scales of the QLQ-C30 and FACT-BMT by patient baseline characteristics and comparing the significant scales in patients with or without specific late complications.
Age and employment status were significantly associated with global quality of life. There were significant differences Professional reintegration after BMT S Bieri et al in several subscales by age at transplant (better in younger patients), by gender (better in men) and by employment status (better in patients employed full time after HSCT). The impact of age and marital status as well as employment status is shown graphically in Figure 2 . Global HQRL was better with younger age at transplant and the impact of marital status was of borderline significance. The differences between married, separated or patients living with a partner are rather small, as shown in Table 4 . As marital status and age are closely linked, young people tend to be single, one has to get married prior to having a divorce.
Perception of HRQL and late complications
In total, 67 patients were not affected by late complications and 57 had one or more of those late complications counting extensive chronic GVHD, second malignancies, renal complications, depression, neurological complications and cataracts. In patients without late complications, 45% reported a good quality of life as opposed to 42% of those with late complications, Po0.77.
There was no late complication that was significantly associated with worse global HRQL (Table 4 ). There were significant associations of some of the dimensions of HRQL with depression (cognitive and emotional function) and there was a trend toward worse physical function in patients with chronic GVHD.
Perception of HRQL and employment status
In total, 119 patients (96%) had an occupation or were in school or training before HSCT. After HSCT, 60% of these patients returned to their activities, 29% returned to fulltime employment, 21% part time and 10% returned to training or school. In total, 40% of the patients did not return to work and depend on disability insurance (39%) or are retired (1%). Among patients fully employed, 73% reported good quality of life as opposed to 22% of those on disability insurance and 28% of those on part-time work (Po0.0001). Figure 2 shows a graphical representation by a boxplot of HRQL by marital status, employment status, presence or absence of chronic GVHD and by age.
Perception of HRQL, transplantation regimen and state of disease A few patients had been transplanted using a reduced intensity conditioning (RIC) regimen (n ¼ 13) (Table 1) , and hence lacking the power for meaningful statistical analysis. Good HRQL was reported in 54% of RIC patients and in 42% of patients with standard conditioning, Po0.43. Among 73 patients with standard risk disease, 38% had a good quality of life as opposed to 51% of 51 patients with high-risk disease, a difference not considered statistically significant different, Po0.2. 
Multivariate logistic regression analysis
Results of a multivariate logistic regression analysis are not presented as only the two variables with a significant impact on global HRQL entered into the models. These variables are patient age at transplantation and employment status. As there was partial correlation between these variables, independent effects could not be estimated. Young age at transplantation had a significant impact on the perception of HRQL, hazard ratio (HR) 0.27 (95% CI 0.12-0.59) Po0.001. There was also a strong correlation between age and marital status with young patients reporting good HRQL and being single. All other variables were not significantly associated with global HRQL as measured by the QLQ-C30 in a logistic regression dichotomizing global HRQL into 80-100 and less. If employment status post transplant was included, then this was the most and only significant variable with patients with full employment having best quality of life, HR 0.35 (95% CI 0.22-0.58) Po0.0001.
Discussion
A considerable proportion of HSCT recipients become long-term survivors. The aim of this single-center study was to identify pre-and post-transplantation characteristics associated with perception of quality of life cross-sectionally, to compare HRQL in patients after HSCT to normal controls and to correlate the HRQL with professional reintegration after HSCT and with marital status and other somatic variables. There are few studies concentrating exclusively on recipients of allogeneic BMTs, and the instruments used to measure HRQL are heterogeneous making comparisons difficult. Sociodemographic variables should be taken into consideration when interpreting HRQL scores. 18, 20 Significant differences in HRQL among groups defined by educational level, age and gender were reported. Those variables were analyzed in the present study except for educational level, as we lack this information. Although this study had an excellent rate of participation of 94%, several limitations should be taken into account: first, it was a cross-sectional study with a modest number of participants, patients were heterogeneous, and second, the comparison with a healthy population may not have been entirely adequate as the most important question to be asked is whether HSCT recipients differ from similar patients (for example, diagnosis, age and social background) treated by methods other than HSCT.
Age o25 years at HSCT and return to full-time work were the only parameters significantly associated with a better perception of HRQL. Regarding age, there is indeed Professional reintegration after BMT S Bieri et al Table 4 Outcome variables between HRQL, HSCT-related variables, late complications and sociodemographic variables Professional reintegration after BMT S Bieri et al a strong correlation between age at transplant and age at last follow-up and there is also a correlation between age and duration of follow-up, as in the 1980s only young patients used to be transplanted, and these patients do obviously have the longest follow-up time. We noted some gender differences with emotional and cognitive function being worse in women and fatigue being worse in men. The global score was not different. There were no significant gender differences in the FACT-BMT score. We do not have a good explanation for these discrepancies. The absence of significant differences in the global QLQ-30 score may be due to the fact that differences in various dimensions with effects in opposing directions may cancel each other out. Gender differences in HRQL after HSCT were described in the literature. 4, 7, 22, 23 Perception of HRQL may depend on the severity of initial disease state, but in the present study, we did not find a statistically significant difference. There was a tendency toward a better HRQL in high-risk long-term survivors. Overall good HRQL among long-term survivors of allogeneic BMT is common. [4] [5] [6] [7] 24, 25 However, late complications, chronic extensive GVHD or older age at BMT are considered to be negative predictors of HRQL. 2, 4, 23 The present analysis showed that age was associated with a worse perception of global HRQL. This is consistent with other studies reported in the literature. 2, 4, 18, 23 However, even if HRQL analyses have not always been done with the same instruments, a high level of satisfaction with life quality and a progressive improvement over time has been frequently described. [1] [2] [3] [5] [6] [7] 23, 24, 26 It has been suggested that full recovery after HSCT may be a 3-to 5-year process. 3, 7, 24 Indeed, Kopp et al. 26 observed in a investigation with the EORTC QLQ-C30 and FACT-BMT questionnaires that HRQL improves significantly within 1 year after HSCT. In the present study, however, a significant correlation between HRQL and follow-up time was not observed. We do not have a good explanation for this difference compared to other studies, but might be related to the fact that older patients do have shorter follow-up times than young patients as discussed above. Our data do not support the hypothesis that this lack of improvement over time may be due to a high proportion of patients on disability insurance, as patients returning to part-time work do not differ in HRQL whether they do or do not have in addition a partial disability insurance (Figure 2) .
Work activity in the general population has been found to have an important relationship with quality of life and sense of well-being. There are a number of reasons for loss of role functioning including changes in physical health and the capacity to rehabilitate in professional life. A significant correlation of perceived HRQL with post-transplant employment status was found and this is not surprising as it is well established that employed people rate their HRQL higher than non-employed peoples. 27 In the present study, return to work was significantly associated with better perception of HRQL in all the functional domains of the QLQ-C30 and FACT-BMT. These results are difficult to interpret, as it is not clear whether patients return to work because of good HRQL or whether HRQL improves through professional activity and the rewarding role of a breadwinner. According to the literature, approximately 60-90% of HSCT survivors return to work, with higher rates noted in office than in physically demanding jobs, 2,4,6,7,25 but here only 29% of patients returned to full-time employment post-BMT. The reasons for this low rate may be in part related to the lack of a well-defined reintegration program in our center 15 years ago and relatively easy access to disability insurance at that time.
We conclude from the present study that the perception of quality of life after HSCT is below the general population. Issues to increase work-related capabilities and improve social support need to be addressed.
